Calamos Advisors LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Calamos Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 12, 2021	SELL	$74.73 - $90.69 $8.22 Million - $9.98 Million	-110,000 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$72.61 - $90.2 $5.37 Million - $6.67 Million	74,000 Added 205.56%	110,000 $9.65 Million
Q3 2020 Oct 26, 2020	SELL	$71.87 - $131.03 $862,440 - $1.57 Million	-12,000 Reduced 25.0%	36,000 $2.74 Million
Q2 2020 Jul 27, 2020	BUY	$79.55 - $124.22 $3.82 Million - $5.96 Million	48,000 New	48,000 $5.92 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.